Navigation Links
InaVein, LLC Announces First Peer-reviewed Publication of TRIVEX® Used In-Office
Date:10/20/2011

LEXINGTON, Mass., Oct. 20, 2011 /PRNewswire/ -- InaVein, LLC today announced publication of a peer-reviewed paper that examines use of the TRIVEX transilluminated powered phlebectomy (TIPP) System for removal of varicose veins in a clinical office rather than a hospital setting. The paper, Transilluminated Powered Phlebectomy in an Office Setting:  Procedural Considerations and Clinical Outcomes was authored by Gregory A. Spitz, M.D., FACS (AmeriVein Systems, Aurora, Illinois) and published in the October 2011 edition of the Journal of Endovascular Therapy.  The TRIVEX procedure was successfully completed on all patients using only local tumescent anesthesia.  There were no reports of hematomas, deep vein thrombosis, or extended parasthesia at the 3-month follow up.  Patients reported a high level of satisfaction (9.6 out of 10) in this setting. A mean procedure time of 13.5 minutes (+/-3.7 min) was reported.  Thirty-three of the 36 patients underwent concurrent endovenous ablation procedures.  According to Dr. Spitz, "More recent cases have confirmed that when patients are prepared for an in-office procedure and treated by a physician well versed in the TIPP procedure and tumescent anesthesia, the outcomes are mutually satisfying. There should also be an economic benefit, with reduced cost to the healthcare system, as has been realized in other clinical situations."  InaVein CEO Keith Jansen said, "This clinical evidence highlights the benefits of the TRIVEX procedure in an office environment for patients who have varicose veins -- a condition that impacts 25 - 40 million Americans and over 700 million people globally."

About InaVein

InaVein, LLC is a privately held company engaged in the development, manufacture, marketing and commercialization of unique medical devices for the treatment of vein disease. The company's flagship product, The TRIVEX System, is the first technology to provide ve
'/>"/>

SOURCE InaVein, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Epilepsy Therapy Project Announces "Shark Tank" Competition to Identify the Most Innovative, New Products for People with Epilepsy
2. China Nuvo Solar, Inc. Announces Corporate Name Change to SurgLine International, Inc.
3. Misonix Announces the Sale of Its Laboratory and Forensic Safety Products Business for $1.5 Million
4. The Society for Minimally Invasive Spine Surgery Announces Agreement With joimax® to Support Creation and Launch of SMISS Registry for Endoscopic Spine Surgery
5. WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System
6. Sequenom, Inc. Announces Date of Third Quarter 2011 Financial Results and Conference Call
7. Bend Research Announces New Chief Financial Officer
8. Young Innovations, Inc. Announces Record EPS for the Quarter and Record Sales and EPS for the Nine-Months Ended September 30, 2011 and Declares Quarterly Dividend
9. Amgen Announces Webcast of 2011 Third Quarter Financial Results
10. Pacira Pharmaceuticals, Inc. Announces New Data Demonstrating Longer Time to First Opioid Use and Reduction in Opioid-Related Adverse Events With EXPAREL™ Compared to Bupivacaine HCl
11. Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)...  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ) ("Juniper" ... three-month period ended March 31, 2015. First quarter financial highlights ... increase of 19% as compared to $7.0 million in ... increased 41% year-over-year, enabled by the return of normalized ... in the fourth quarter of 2014; , Service ...
(Date:5/6/2015)... , May 6, 2015 ... therapy with dolutegravir and rilpivirine   ... a Phase III clinical trial programme to evaluate ... rilpivirine (Edurant® [1] ) as maintenance therapy for ... comprises two replicate studies evaluating 48 week viral ...
(Date:5/6/2015)... Woodford Patient Capital Trust ... and the Bill & Melinda Gates Foundation to ... leading monoclonal antibody biopharmaceutical company, announced today that ... to complete a US$90 million Series B financing. ... Patient Capital Trust plc (LSE:WPCT,"Woodford") and Malin Corporation ...
Breaking Medicine Technology:Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4
(Date:5/6/2015)... (PRWEB) May 06, 2015 The GUARDaHEART ... Starbucks Community Resource Exchange with the mission of providing ... County families in need on Thursday, April 30th. ... an advanced blood test for the early-detection and diagnosis ... life changing advanced medical testing to homeless individuals and ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 On ... Choices Recovery sponsored Durkin Entertainment’s “RockNRolla” EcoLuxe Lounge, ... providers of products and services that maintain ecologically ... Durkin, Los Angeles’ leading producer of TV and ... is a premier red carpet event that makes ...
(Date:5/6/2015)... 06, 2015 Aging2.0 - ... announced the latest lineup of speakers and sponsors for ... invitation-only event, scheduled for May 18-19 in San Francisco, ... consumer technology leaders, investors and more than 50 startups ... partnerships and discover new products and services for the ...
(Date:5/6/2015)... National Physical Fitness and Sports Month , The ... Department of Health and Human Services (HHS), designates the ... Month. It is dedicated to raising public awareness ... Throughout the month of May, Americans are challenged to ... HHS details the benefits of regular daily and weekly ...
(Date:5/6/2015)... Established by the Arthritis Foundation, the ... 46 million Americans who suffer from arthritis. Many who ... alleviate their symptoms. Medicationdiscountcard.com is proud to offer a ... on the costs of these necessary prescriptions. , Non-Steroidal ... the pain and inflammation in the joints associated with ...
Breaking Medicine News(10 mins):Health News:GUARDaHEART and Starbucks® Collaborate for Impactful Event to Help Homeless Families 2Health News:Choices Recovery Mishawaka Discusses the Many Forms of Addiction and Treatment with Terrah Bennett Smith 2Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 2Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 3Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 4Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 2Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 3Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3
... TV coverage of terrorism has more negative effect on women. ... University of Haifa. "It is possible that the differences between ... to respond to terrorism with more anxiety than men," said ... Exposure to television coverage of terrorism causes women ...
... By Serena Gordon HealthDay Reporter , ... treatment performed significantly better than the commonly prescribed medication ... briakinumab reduced psoriasis symptoms by at least 75 percent ... to just 40 percent of those on methotrexate. But ...
... THURSDAY, Oct. 27 (HealthDay News) -- Older people who ... greater risk for complications and disability following surgery, according ... of Colorado said surgeons should assess the elderly differently ... when determining surgical risks. "This approach may lead ...
... Endocrine Society,s Journal of Clinical Endocrinology & Metabolism ... associated with reduced loss of lean muscle mass in older ... these men, higher testosterone levels were also associated with less ... and strength contribute to frailty and are associated with falls, ...
... D.C. -- A new study suggests some women needing a ... potential option that is safe and effective, say researchers at ... sparing mastectomy is also a viable surgical option for women ... increased risk of developing the disease. For both groups ...
... was found to be ineffective in reducing atherosclerosis ... erythematosus (SLE). Results of the Atherosclerosis Prevention in ... Arthritis & Rheumatism , a journal published ... of Rheumatology (ACR), report that the statin therapy ...
Cached Medicine News:Health News:Gender differences: Viewing TV coverage of terrorism has more negative effect on women 2Health News:Experimental Psoriasis Drug Bests Older Treatment 2Health News:Experimental Psoriasis Drug Bests Older Treatment 3Health News: Slower Walking Speed Linked to Surgical Risk in Elderly 2Health News: Slower Walking Speed Linked to Surgical Risk in Elderly 3Health News:Older men with higher testosterone levels lose less muscle mass as they age 2Health News:Georgetown researchers examine 21-year series of nipple sparing mastectomy cases and find no cancers 2Health News:Statin therapy fails to slow progression of atherosclerosis in pediatric lupus patients 2
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
The perfect tool to prepare for in-service or licensing exams, for recertification, or for use as a clinical refresher....
... Med TruFlow™ Oxygen flowmeter with a Lexan®inner ... covering calibration and manufacturing defects. A wide ... most needs. Also available with all popular ... take-off and double unit configurations. Our extra ...
... TruFlow™ Oxygen flowmeter with a Lexan®inner calibrated ... calibration and manufacturing defects. A wide range ... needs. Also available with all popular inlet ... and double unit configurations. Our extra large ...
Medicine Products: